Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 157 to 168 of 168 entries
Sorted by: Best Match Show Resources per page
Do agricultural grasses bred for improved root systems provide resilience to machinery-derived soil compaction?.

Food and energy security

Muhandiram NPK, Humphreys MW, Fychan R, Davies JW, Sanderson R, Marley CL.
PMID: 32999718
Food Energy Secur. 2020 Aug;9(3):e227. doi: 10.1002/fes3.227. Epub 2020 Jul 05.

The increasing frequency of droughts and floods on grasslands, due to climate change, increases the risk of soil compaction. Soil compaction affects both soil and forage productivity. Differing grasses may counteract some effects of compaction due to differences in...

Cite
Muhandiram NPK, Humphreys MW, Fychan R, et al. Do agricultural grasses bred for improved root systems provide resilience to machinery-derived soil compaction?. Food Energy Secur. 2020;9(3):e227doi: 10.1002/fes3.227.
Muhandiram, N. P. K., Humphreys, M. W., Fychan, R., Davies, J. W., Sanderson, R., & Marley, C. L. (2020). Do agricultural grasses bred for improved root systems provide resilience to machinery-derived soil compaction?. Food and energy security, 9(3), e227. https://doi.org/10.1002/fes3.227
Muhandiram, Nuwan P K, et al. "Do agricultural grasses bred for improved root systems provide resilience to machinery-derived soil compaction?." Food and energy security vol. 9,3 (2020): e227. doi: https://doi.org/10.1002/fes3.227
Muhandiram NPK, Humphreys MW, Fychan R, Davies JW, Sanderson R, Marley CL. Do agricultural grasses bred for improved root systems provide resilience to machinery-derived soil compaction?. Food Energy Secur. 2020 Aug;9(3):e227. doi: 10.1002/fes3.227. Epub 2020 Jul 05. PMID: 32999718; PMCID: PMC7507784.
Copy Download .nbib Format: NLM
Genotype and Environment Affect the Grain Quality and Yield of Winter Oats (.

Foods (Basel, Switzerland)

Howarth CJ, Martinez-Martin PMJ, Cowan AA, Griffiths IM, Sanderson R, Lister SJ, Langdon T, Clarke S, Fradgley N, Marshall AH.
PMID: 34681405
Foods. 2021 Oct 03;10(10). doi: 10.3390/foods10102356.

The extent to which the quality and yield of plant varieties are influenced by the environment is important for their successful uptake by end users particularly as climatic fluctuations are resulting in environments that are highly variable from one...

Cite
Howarth CJ, Martinez-Martin PMJ, Cowan AA, et al. Genotype and Environment Affect the Grain Quality and Yield of Winter Oats (. Foods. 2021;10(10)doi: 10.3390/foods10102356.
Howarth, C. J., Martinez-Martin, P. M. J., Cowan, A. A., Griffiths, I. M., Sanderson, R., Lister, S. J., Langdon, T., Clarke, S., Fradgley, N., & Marshall, A. H. (2021). Genotype and Environment Affect the Grain Quality and Yield of Winter Oats (. Foods (Basel, Switzerland), 10(10), . https://doi.org/10.3390/foods10102356
Howarth, Catherine J, et al. "Genotype and Environment Affect the Grain Quality and Yield of Winter Oats (." Foods (Basel, Switzerland) vol. 10,10 (2021). doi: https://doi.org/10.3390/foods10102356
Howarth CJ, Martinez-Martin PMJ, Cowan AA, Griffiths IM, Sanderson R, Lister SJ, Langdon T, Clarke S, Fradgley N, Marshall AH. Genotype and Environment Affect the Grain Quality and Yield of Winter Oats (. Foods. 2021 Oct 03;10(10). doi: 10.3390/foods10102356. PMID: 34681405; PMCID: PMC8535078.
Copy Download .nbib Format: NLM
Exploiting Routine Clinical Measures to Inform Strategies for Better Hearing Performance in Cochlear Implant Users.

Frontiers in neuroscience

Sanderson AP, Rogers ETF, Verschuur CA, Newman TA.
PMID: 30697145
Front Neurosci. 2019 Jan 15;12:1048. doi: 10.3389/fnins.2018.01048. eCollection 2018.

Neuroprostheses designed to interface with the nervous system to replace injured or missing senses can significantly improve a patient's quality of life. The challenge remains to provide implants that operate optimally over several decades. Changes in the implant-tissue interface...

Cite
Sanderson AP, Rogers ETF, Verschuur CA, et al. Exploiting Routine Clinical Measures to Inform Strategies for Better Hearing Performance in Cochlear Implant Users. Front Neurosci. 2019;12:1048doi: 10.3389/fnins.2018.01048.
Sanderson, A. P., Rogers, E. T. F., Verschuur, C. A., & Newman, T. A. (2018). Exploiting Routine Clinical Measures to Inform Strategies for Better Hearing Performance in Cochlear Implant Users. Frontiers in neuroscience, 121048. https://doi.org/10.3389/fnins.2018.01048
Sanderson, Alan P, et al. "Exploiting Routine Clinical Measures to Inform Strategies for Better Hearing Performance in Cochlear Implant Users." Frontiers in neuroscience vol. 12 (2018): 1048. doi: https://doi.org/10.3389/fnins.2018.01048
Sanderson AP, Rogers ETF, Verschuur CA, Newman TA. Exploiting Routine Clinical Measures to Inform Strategies for Better Hearing Performance in Cochlear Implant Users. Front Neurosci. 2019 Jan 15;12:1048. doi: 10.3389/fnins.2018.01048. eCollection 2018. PMID: 30697145; PMCID: PMC6340939.
Copy Download .nbib Format: NLM
Integrative Omic Profiling Reveals Unique Hypoxia Induced Signatures in Gastric Cancer Associated Myofibroblasts.

Cancers

Najgebauer H, Jarnuczak AF, Varro A, Sanderson CM.
PMID: 30813438
Cancers (Basel). 2019 Feb 23;11(2). doi: 10.3390/cancers11020263.

Although hypoxia is known to contribute to several aspects of tumour progression, relatively little is known about the effects of hypoxia on cancer-associated myofibroblasts (CAMs), or the consequences that conditional changes in CAM function may have on tumour development...

Cite
Najgebauer H, Jarnuczak AF, Varro A, et al. Integrative Omic Profiling Reveals Unique Hypoxia Induced Signatures in Gastric Cancer Associated Myofibroblasts. Cancers (Basel). 2019;11(2)doi: 10.3390/cancers11020263.
Najgebauer, H., Jarnuczak, A. F., Varro, A., & Sanderson, C. M. (2019). Integrative Omic Profiling Reveals Unique Hypoxia Induced Signatures in Gastric Cancer Associated Myofibroblasts. Cancers, 11(2), . https://doi.org/10.3390/cancers11020263
Najgebauer, Hanna, et al. "Integrative Omic Profiling Reveals Unique Hypoxia Induced Signatures in Gastric Cancer Associated Myofibroblasts." Cancers vol. 11,2 (2019). doi: https://doi.org/10.3390/cancers11020263
Najgebauer H, Jarnuczak AF, Varro A, Sanderson CM. Integrative Omic Profiling Reveals Unique Hypoxia Induced Signatures in Gastric Cancer Associated Myofibroblasts. Cancers (Basel). 2019 Feb 23;11(2). doi: 10.3390/cancers11020263. PMID: 30813438; PMCID: PMC6406696.
Copy Download .nbib Format: NLM
Early FDG PET response predicts CAR-T failure in large B-cell lymphoma.

Blood advances

Kuhnl A, Roddie C, Kirkwood AA, Menne T, Cuadrado MM, Marzolini MAV, Osborne W, Sanderson R, O'Reilly M, Townsend WM, Benjamin R, Potter V, Patten PE, Yallop D, Voo S, Petrides G, Mulholland N, Kayani I.
PMID: 34700342
Blood Adv. 2021 Oct 26; doi: 10.1182/bloodadvances.2021005807. Epub 2021 Oct 26.

No abstract available.

Cite
Kuhnl A, Roddie C, Kirkwood AA, et al. Early FDG PET response predicts CAR-T failure in large B-cell lymphoma. Blood Adv. 2021;doi: 10.1182/bloodadvances.2021005807.
Kuhnl, A., Roddie, C., Kirkwood, A. A., Menne, T., Cuadrado, M. M., Marzolini, M. A. V., Osborne, W., Sanderson, R., O'Reilly, M., Townsend, W. M., Benjamin, R., Potter, V., Patten, P. E., Yallop, D., Voo, S., Petrides, G., Mulholland, N., & Kayani, I. (2021). Early FDG PET response predicts CAR-T failure in large B-cell lymphoma. Blood advances, . https://doi.org/10.1182/bloodadvances.2021005807
Kuhnl, Andrea, et al. "Early FDG PET response predicts CAR-T failure in large B-cell lymphoma." Blood advances vol. (2021). doi: https://doi.org/10.1182/bloodadvances.2021005807
Kuhnl A, Roddie C, Kirkwood AA, Menne T, Cuadrado MM, Marzolini MAV, Osborne W, Sanderson R, O'Reilly M, Townsend WM, Benjamin R, Potter V, Patten PE, Yallop D, Voo S, Petrides G, Mulholland N, Kayani I. Early FDG PET response predicts CAR-T failure in large B-cell lymphoma. Blood Adv. 2021 Oct 26; doi: 10.1182/bloodadvances.2021005807. Epub 2021 Oct 26. PMID: 34700342.
Copy Download .nbib Format: NLM
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.

Leukemia

Spanjaart AM, Ljungman P, de La Camara R, Tridello G, Ortiz-Maldonado V, Urbano-Ispizua A, Barba P, Kwon M, Caballero D, Sesques P, Bachy E, Di Blasi R, Thieblemont C, Calkoen F, Mutsaers P, Maertens J, Giannoni L, Nicholson E, Collin M, Vaz CP, Metafuni E, Martinez-Lopez J, Dignan FL, Ribera JM, Nagler A, Folber F, Sanderson R, Bloor A, Ciceri F, Knelange N, Ayuk F, Kroger N, Kersten MJ, Mielke S.
PMID: 34750508
Leukemia. 2021 Dec;35(12):3585-3588. doi: 10.1038/s41375-021-01466-0. Epub 2021 Nov 08.

No abstract available.

Cite
Spanjaart AM, Ljungman P, de La Camara R, et al. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group. Leukemia. 2021;35(12):3585-3588doi: 10.1038/s41375-021-01466-0.
Spanjaart, A. M., Ljungman, P., de La Camara, R., Tridello, G., Ortiz-Maldonado, V., Urbano-Ispizua, A., Barba, P., Kwon, M., Caballero, D., Sesques, P., Bachy, E., Di Blasi, R., Thieblemont, C., Calkoen, F., Mutsaers, P., Maertens, J., Giannoni, L., Nicholson, E., Collin, M., Vaz, C. P., Metafuni, E., Martinez-Lopez, J., Dignan, F. L., Ribera, J. M., Nagler, A., Folber, F., Sanderson, R., Bloor, A., Ciceri, F., Knelange, N., Ayuk, F., Kroger, N., Kersten, M. J., & Mielke, S. (2021). Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group. Leukemia, 35(12), 3585-3588. https://doi.org/10.1038/s41375-021-01466-0
Spanjaart, Anne Mea, et al. "Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group." Leukemia vol. 35,12 (2021): 3585-3588. doi: https://doi.org/10.1038/s41375-021-01466-0
Spanjaart AM, Ljungman P, de La Camara R, Tridello G, Ortiz-Maldonado V, Urbano-Ispizua A, Barba P, Kwon M, Caballero D, Sesques P, Bachy E, Di Blasi R, Thieblemont C, Calkoen F, Mutsaers P, Maertens J, Giannoni L, Nicholson E, Collin M, Vaz CP, Metafuni E, Martinez-Lopez J, Dignan FL, Ribera JM, Nagler A, Folber F, Sanderson R, Bloor A, Ciceri F, Knelange N, Ayuk F, Kroger N, Kersten MJ, Mielke S. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group. Leukemia. 2021 Dec;35(12):3585-3588. doi: 10.1038/s41375-021-01466-0. Epub 2021 Nov 08. PMID: 34750508; PMCID: PMC8573311.
Copy Download .nbib Format: NLM
Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3.

Matrix biology : journal of the International Society for Matrix Biology

Knani I, Singh P, Gross-Cohen M, Aviram S, Ilan N, Sanderson RD, Aronheim A, Vlodavsky I.
PMID: 34808335
Matrix Biol. 2021 Nov 20; doi: 10.1016/j.matbio.2021.11.001. Epub 2021 Nov 20.

Activity of heparanase, endoglycosidase that cleaves heparan sulfate side chains in heparan sulfate proteoglycans, is highly implicated in tumor progression and metastasis. Heparanase inhibitors are therefore being evaluated clinically as anti-cancer therapeutics. Heparanase 2 (Hpa2) is a close homolog...

Cite
Knani I, Singh P, Gross-Cohen M, et al. Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3. Matrix Biol. 2021;doi: 10.1016/j.matbio.2021.11.001.
Knani, I., Singh, P., Gross-Cohen, M., Aviram, S., Ilan, N., Sanderson, R. D., Aronheim, A., & Vlodavsky, I. (2021). Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3. Matrix biology : journal of the International Society for Matrix Biology, . https://doi.org/10.1016/j.matbio.2021.11.001
Knani, Ibrahim, et al. "Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3." Matrix biology : journal of the International Society for Matrix Biology vol. (2021). doi: https://doi.org/10.1016/j.matbio.2021.11.001
Knani I, Singh P, Gross-Cohen M, Aviram S, Ilan N, Sanderson RD, Aronheim A, Vlodavsky I. Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3. Matrix Biol. 2021 Nov 20; doi: 10.1016/j.matbio.2021.11.001. Epub 2021 Nov 20. PMID: 34808335.
Copy Download .nbib Format: NLM
Robotic hysterectomy compared with laparoscopic hysterectomy: is it still more costly to perform?.

Journal of robotic surgery

Ghomi A, Nolan W, Sanderson DJ, Sanderson R, Schwander B, Feldstein J.
PMID: 34232449
J Robot Surg. 2021 Jul 07; doi: 10.1007/s11701-021-01273-w. Epub 2021 Jul 07.

To establish the economic value of simple robotic hysterectomy vs laparoscopic hysterectomy and assess the impact of surgeon's experience. Retrospective cohort study. University-affiliated US regional healthcare system. Reproductive and post-menopausal women undergoing hysterectomy for benign indications. Robotic or laparoscopic...

Cite
Ghomi A, Nolan W, Sanderson DJ, et al. Robotic hysterectomy compared with laparoscopic hysterectomy: is it still more costly to perform?. J Robot Surg. 2021;doi: 10.1007/s11701-021-01273-w.
Ghomi, A., Nolan, W., Sanderson, D. J., Sanderson, R., Schwander, B., & Feldstein, J. (2021). Robotic hysterectomy compared with laparoscopic hysterectomy: is it still more costly to perform?. Journal of robotic surgery, . https://doi.org/10.1007/s11701-021-01273-w
Ghomi, Ali, et al. "Robotic hysterectomy compared with laparoscopic hysterectomy: is it still more costly to perform?." Journal of robotic surgery vol. (2021). doi: https://doi.org/10.1007/s11701-021-01273-w
Ghomi A, Nolan W, Sanderson DJ, Sanderson R, Schwander B, Feldstein J. Robotic hysterectomy compared with laparoscopic hysterectomy: is it still more costly to perform?. J Robot Surg. 2021 Jul 07; doi: 10.1007/s11701-021-01273-w. Epub 2021 Jul 07. PMID: 34232449.
Copy Download .nbib Format: NLM
Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma.

Blood advances

Kuhnl A, Roddie C, Kirkwood AA, Menne T, Cuadrado M, Marzolini MAV, Osborne W, Sanderson R, O'Reilly M, Townsend W, Benjamin R, Potter V, Patten PEM, Yallop D, Voo S, Petrides GS, Mulholland N, Kayani I.
PMID: 34700342
Blood Adv. 2022 Jan 11;6(1):321-326. doi: 10.1182/bloodadvances.2021005807.

No abstract available.

Cite
Kuhnl A, Roddie C, Kirkwood AA, et al. Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma. Blood Adv. 2022;6(1):321-326doi: 10.1182/bloodadvances.2021005807.
Kuhnl, A., Roddie, C., Kirkwood, A. A., Menne, T., Cuadrado, M., Marzolini, M. A. V., Osborne, W., Sanderson, R., O'Reilly, M., Townsend, W., Benjamin, R., Potter, V., Patten, P. E. M., Yallop, D., Voo, S., Petrides, G. S., Mulholland, N., & Kayani, I. (2022). Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma. Blood advances, 6(1), 321-326. https://doi.org/10.1182/bloodadvances.2021005807
Kuhnl, Andrea, et al. "Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma." Blood advances vol. 6,1 (2022): 321-326. doi: https://doi.org/10.1182/bloodadvances.2021005807
Kuhnl A, Roddie C, Kirkwood AA, Menne T, Cuadrado M, Marzolini MAV, Osborne W, Sanderson R, O'Reilly M, Townsend W, Benjamin R, Potter V, Patten PEM, Yallop D, Voo S, Petrides GS, Mulholland N, Kayani I. Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma. Blood Adv. 2022 Jan 11;6(1):321-326. doi: 10.1182/bloodadvances.2021005807. PMID: 34700342.
Copy Download .nbib Format: NLM
Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity.

BMJ neurology open

Sokolov E, Karschnia P, Benjamin R, Hadden RDM, Elwes RCD, Drummond L, Amin D, Paiva V, Pennisi A, Herlopian A, Frigault M, Sanderson R, Inam S, Cole AJ, Dietrich J.
PMID: 33681787
BMJ Neurol Open. 2020 Jun 18;2(1):e000054. doi: 10.1136/bmjno-2020-000054. eCollection 2020.

Chimeric antigen receptor-modified T cells (CAR-T) have emerged as a promising immunotherapeutic approach in relapsed/refractory haematolgical malignancies. Broader application is limited by unique toxicities, notably, neurotoxicity (NTX). Language dysfunction is among the most frequent symptoms of NTX, the underlying...

Cite
Sokolov E, Karschnia P, Benjamin R, et al. Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity. BMJ Neurol Open. 2020;2(1):e000054doi: 10.1136/bmjno-2020-000054.
Sokolov, E., Karschnia, P., Benjamin, R., Hadden, R. D. M., Elwes, R. C. D., Drummond, L., Amin, D., Paiva, V., Pennisi, A., Herlopian, A., Frigault, M., Sanderson, R., Inam, S., Cole, A. J., & Dietrich, J. (2020). Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity. BMJ neurology open, 2(1), e000054. https://doi.org/10.1136/bmjno-2020-000054
Sokolov, Elisaveta, et al. "Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity." BMJ neurology open vol. 2,1 (2020): e000054. doi: https://doi.org/10.1136/bmjno-2020-000054
Sokolov E, Karschnia P, Benjamin R, Hadden RDM, Elwes RCD, Drummond L, Amin D, Paiva V, Pennisi A, Herlopian A, Frigault M, Sanderson R, Inam S, Cole AJ, Dietrich J. Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity. BMJ Neurol Open. 2020 Jun 18;2(1):e000054. doi: 10.1136/bmjno-2020-000054. eCollection 2020. PMID: 33681787; PMCID: PMC7871716.
Copy Download .nbib Format: NLM
Suppression of telomere capping defects of Saccharomyces cerevisiae yku70 and yku80 mutants by telomerase.

G3 (Bethesda, Md.)

Holland CL, Sanderson BA, Titus JK, Weis MF, Riojas AM, Malczewskyj E, Wasko BM, Lewis LK.
PMID: 34718547
G3 (Bethesda). 2021 Dec 08;11(12). doi: 10.1093/g3journal/jkab359.

The Ku complex performs multiple functions inside eukaryotic cells, including protection of chromosomal DNA ends from degradation and fusion events, recruitment of telomerase, and repair of double-strand breaks (DSBs). Inactivation of Ku complex genes YKU70 or YKU80 in cells...

Cite
Holland CL, Sanderson BA, Titus JK, et al. Suppression of telomere capping defects of Saccharomyces cerevisiae yku70 and yku80 mutants by telomerase. G3 (Bethesda). 2021;11(12)doi: 10.1093/g3journal/jkab359.
Holland, C. L., Sanderson, B. A., Titus, J. K., Weis, M. F., Riojas, A. M., Malczewskyj, E., Wasko, B. M., & Lewis, L. K. (2021). Suppression of telomere capping defects of Saccharomyces cerevisiae yku70 and yku80 mutants by telomerase. G3 (Bethesda, Md.), 11(12), . https://doi.org/10.1093/g3journal/jkab359
Holland, Cory L, et al. "Suppression of telomere capping defects of Saccharomyces cerevisiae yku70 and yku80 mutants by telomerase." G3 (Bethesda, Md.) vol. 11,12 (2021). doi: https://doi.org/10.1093/g3journal/jkab359
Holland CL, Sanderson BA, Titus JK, Weis MF, Riojas AM, Malczewskyj E, Wasko BM, Lewis LK. Suppression of telomere capping defects of Saccharomyces cerevisiae yku70 and yku80 mutants by telomerase. G3 (Bethesda). 2021 Dec 08;11(12). doi: 10.1093/g3journal/jkab359. PMID: 34718547; PMCID: PMC8664480.
Copy Download .nbib Format: NLM
Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy.

Inflammatory bowel diseases

Hashim A, Patten PEM, Kuhnl A, Ooft ML, Hayee B, Sanderson R.
PMID: 33252123
Inflamm Bowel Dis. 2021 Mar 15;27(4):e45-e46. doi: 10.1093/ibd/izaa320.

No abstract available.

Cite
Hashim A, Patten PEM, Kuhnl A, et al. Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy. Inflamm Bowel Dis. 2021;27(4):e45-e46doi: 10.1093/ibd/izaa320.
Hashim, A., Patten, P. E. M., Kuhnl, A., Ooft, M. L., Hayee, B., & Sanderson, R. (2021). Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy. Inflammatory bowel diseases, 27(4), e45-e46. https://doi.org/10.1093/ibd/izaa320
Hashim, Ahmed, et al. "Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy." Inflammatory bowel diseases vol. 27,4 (2021): e45-e46. doi: https://doi.org/10.1093/ibd/izaa320
Hashim A, Patten PEM, Kuhnl A, Ooft ML, Hayee B, Sanderson R. Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy. Inflamm Bowel Dis. 2021 Mar 15;27(4):e45-e46. doi: 10.1093/ibd/izaa320. PMID: 33252123.
Copy Download .nbib Format: NLM
Showing 157 to 168 of 168 entries